TG Therapeutics | TGTX - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 15B 1.62B 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 8.62B 1.28B 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
Arrowhead Research USD 73.74M 190.29M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Biogen USD 2.25B 30M 2026-03
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Curis USD 1.14M 1.41M 2025-12
Gilead Sciences USD 7B 930M 2026-03
J&J USD 24.1B 500M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Novartis USD 13.11B 226M 2026-03
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
TG Therapeutics USD 194.8M 2.23M 2026-03
Verastem USD 17.54M 7.53M 2025-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03